Rezolute, Inc. - Common Stock — Cash Flow (NASDAQ:RZLT) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -20.44 M-39.62 M-44.48 M-57.37 M-69.08 M -73.48 M Cash from investing activities 0—-101.46 M48.7 M-14.54 M -33.05 M Cash from financing activities 51.53 M148.98 M11.57 M63.03 M107.33 M 103.17 M Free cash flow -20.44 M-39.62 M-44.48 M-57.37 M-69.08 M -73.48 M

News

Rezolute: Sell Rating Despite FDA Feedback From Type B Meeting For Ersodetug (NASDAQ:RZLT)

Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update

Alger Small Cap Growth Fund Q4 2025 Portfolio Update

Jefferies reiterates Buy rating on Rezolute stock, maintains $4 target

Rezolute shares mixed results from Phase 3 trial for rare disease therapy

Leerink Partners reiterates Outperform rating on XOMA stock at $45 target

RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know

Rezolute CFO Evans buys shares worth $79,577

Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares

Rezolute’s CCO Karnawat buys $19,598 in shares

Down 81.8% in 4 Weeks, Here's Why Rezolute (RZLT) Looks Ripe for a Turnaround

Micron, Nike Set To Report Earnings Next Week